drug · small molecule
patient view →roxadustat
Phase 2updated 2mo agoby $KYNB KYNTRA BIO, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for chronic kidney disease and anemia (phenotype) and 4 investigational indications.
targets
Hypoxia-inducible factor prolyl hydroxylase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that